Effect of Jinlida Granules on Visceral Fat Accumulation in Prediabetic Rats
10.13422/j.cnki.syfjx.20220839
- VernacularTitle:津力达颗粒对糖尿病前期大鼠内脏脂肪蓄积的影响
- Author:
Shao-lan ZHANG
1
;
Yun-long HOU
2
;
Kun MA
1
;
Jia-meng HAO
3
;
Cui-ru LI
1
;
Ya-hui SONG
1
;
Cong WEI
1
Author Information
1. Hebei University of Chinese Medicine，Shijiazhuang 050091，China
2. National Key Laboratory of Collateral Disease Research and Innovative Chinese Medicine，Shijiazhuang 050035，China
3. Hebei Medical University， Shijiazhuang 050017，China
- Publication Type:Journal Article
- Keywords:
Jinlida granules;
visceral fat;
micro-computed tomography （Micro-CT）;
insulin resistance;
prediabetes
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2022;28(8):37-45
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo study the effect of Jinlida granules on visceral fat accumulation and its induced inflammatory response in prediabetic rats. MethodMale SD rats were randomly divided into normal group， model group， Jinlida low-dose group （1.5 g·kg-1）， Jinlida high-dose group （3.0 g·kg-1） and atorvastatin group （10 mg·kg-1）. Prediabetic rat model was established using high-carbohydrate， high-fat diet combined with low-dose streptozotocin （STZ） by multiple small-dose intraperitoneal injections. After 8 weeks of modeling and drug intervention for 13 consecutive weeks， body weight， oral glucose tolerance test（OGTT）， fasting blood glucose （FBG）， fasting insulin （FINS）， insulin resistance index （HOMA-IR）， total cholesterol （TC）， low-density lipoprotein cholesterol （LDL-C） and high-density lipoprotein cholesterol （HDL-C） were measured in each group of rats. The content of visceral fat was quantified by micro-computed tomography （Micro-CT）. Hematoxylin-eosin staining （HE） was used to observe the pathological changes of fat cells. The levels of tumor necrosis factor-α （TNF-α） and interleukin- 6 （IL-6） in rat visceral fat and serum were determined by enzyme linked immunosorbent assay （ELISA）. The expression of macrophage marker CD68 in visceral fat was detected by immunofluorescence and Western blot. ResultCompared with normal group， model group had increased oral glucose tolerance， FBG， FINS， HOMA-IR， TC， LDL-C （P<0.01）， elevated body weight and visceral fat accumulation （P<0.05， P<0.01）， enhanced CD68 protein expression and TNF-α and IL-6 levels （P<0.01）， decreased HDL-C （P<0.01）， and abnormal hypertrophy of adipocytes. Compared with model group， Jinlida high- and low-dose groups lowered oral glucose tolerance， HOMA-IR， TC and LDL-C （P<0.05， P<0.01）， body weight and visceral fat accumulation （P<0.05）， and CD68 protein expression and TNF-α and IL-6 levels （P<0.05， P<0.01） and lessened hypertrophy of fat cells. ConclusionJinlida can improve the insulin resistance in prediabetic rats by reducing visceral fat accumulation and its induced inflammatory response， which provides a new pharmacological basis for clinical treatment of prediabetes by Jinlida granules.
